Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
The European Respiratory Journal
|
March 2, 2012
Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study
B Crestani, J Chapron, B Wallaert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
J Mazières, F Barlesi, T Filleron, et al.
The Review of Scientific Instruments
|
December 3, 2016
A new setup for localized implantation and live-characterization of keV energy multiply charged ions at the nanoscale
S Guillous, C Bourin, B Ban D'Etat, et al.
ESMO Open
|
December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer
O Molinier, B Besse, F Barlesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
S Peters, A Scherpereel, R Cornelissen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program
C Leduc, J P Merlio, B Besse, et al.
Respiratory Medicine and Research
|
May 17, 2020
Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST study
C Fontaine-Delaruelle, J Mazières, J Cadranel, et al.
Scientific Reports
|
July 19, 2014
Energy deposition by heavy ions: additivity of kinetic and potential energy contributions in hillock formation on CaF2
Y Y Wang, C Grygiel, C Dufour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
J Remon, B Besse, S Ponce Aix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial
D Moro-Sibilot, N Cozic, M Pérol, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
The European Respiratory Journal
|
March 2, 2012
Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study
B Crestani, J Chapron, B Wallaert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
J Mazières, F Barlesi, T Filleron, et al.
The Review of Scientific Instruments
|
December 3, 2016
A new setup for localized implantation and live-characterization of keV energy multiply charged ions at the nanoscale
S Guillous, C Bourin, B Ban D'Etat, et al.
ESMO Open
|
December 25, 2021
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer
O Molinier, B Besse, F Barlesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 6, 2022
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
S Peters, A Scherpereel, R Cornelissen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program
C Leduc, J P Merlio, B Besse, et al.
Respiratory Medicine and Research
|
May 17, 2020
Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST study
C Fontaine-Delaruelle, J Mazières, J Cadranel, et al.
Scientific Reports
|
July 19, 2014
Energy deposition by heavy ions: additivity of kinetic and potential energy contributions in hillock formation on CaF2
Y Y Wang, C Grygiel, C Dufour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
J Remon, B Besse, S Ponce Aix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial
D Moro-Sibilot, N Cozic, M Pérol, et al.
Page
of 8